A share price of Perspective Therapeutics Inc [CATX] is currently trading at $1.48, up 4.23%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CATX shares have gain 24.37% over the last week, with a monthly amount glided 45.10%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, March 2024, Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results. In a post published today on Yahoo Finance, Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a business update and announced fiscal year 2023 financial results for the period ended December 31, 2023.
From an analyst’s perspective:
Perspective Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.20 and $1.53. Perspective Therapeutics Inc [AMEX: CATX] shares were valued at $1.48 at the most recent close of the market.
Analyzing the CATX fundamentals
Trailing Twelve Months sales for Perspective Therapeutics Inc [AMEX:CATX] were 8.84M which represents 27.26% growth. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -5.13%, Pretax Profit Margin comes in at -4.94%, and Net Profit Margin reading is -3.4%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.25 and Total Capital is -0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3933 points at the first support level, and at 1.3067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5833, and for the 2nd resistance point, it is at 1.6867.
Perspective Therapeutics Inc [CATX] reported earnings per share of -$0.09 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.04/share, meaning a difference of -$0.05 and a surprise factor of -125.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.04 per share as compared to estimates of -$0.04 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Perspective Therapeutics Inc [AMEX:CATX] is 2.67. Further, the Quick Ratio stands at 2.55, while the Cash Ratio is 2.22. Considering the valuation of this stock, the price to sales ratio is 98.26, the price to book ratio is 4.20.
Transactions by insiders
Recent insider trading involved Lantheus Alpha Therapy, LLC, 10% Owner, that happened on Mar 06 ’24 when 60.43 million shares were purchased. Director, Williamson Robert F III completed a deal on Jan 30 ’24 to buy 0.13 million shares. Meanwhile, Director Williamson Robert F III bought 25266.0 shares on Jan 29 ’24.
